retatrutide in australia Research Guide: What the Phase 2 Trial Data Reported (2026) ALERT: Health officials have warned

Molecular Identity Developer Eli Lilly Mechanism Triple GLP-1, GIP, and glucagon receptor agonist FDA Status Under regulatory review (Phase 3 complete) Administration Weekly subcutaneous Triple-Agonist Mechanism Retatrutide combines all pathways: GLP-1: Core incretin signaling (shared with both Mazdutide and Tirzepatide) GIP: Second incretin pathway (shared with Tirzepatide, absent in Mazdutide) Glucagon: Hepatic energy expenditure (shared with Mazdutide, absent in Tirzepatide) For research examining the contributions of all three pathways, Retatrutide provides comprehensive coverage

This does not always mean something is wrong

We did not get a human email response for over a week during our test

Published in The Lancet: June 2026

Snack, if appetite allows : A hard-boiled egg or beef sticks and meat snacks made from quality meat, easy to eat in a few bites when a full meal isn't practical